Jason Drew Smith
General Counsel · 2 filings · Latest: Sep 7, 2026
UroGen Pharma Ltd.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
URGN | Jason Drew Smith | General Counsel | Sep 8, 2026 | Sale | $42.54 | 1,519 | $64.6K | 53,141 | |
URGN | Jason Drew Smith | General Counsel | Sep 7, 2026 | Option Exercise | — | 3,334 | — | 54,660 | |
URGN | Jason Smith | — | Sep 8, 2026 | Proposed Sale | $44.09 | 1,519 | $67.0K | — | |
URGN | Jason Drew Smith | General Counsel | Feb 3, 2026 | Sale | $19.69 | 7,479 | $147.3K | 55,588 | |
URGN | Jason Drew Smith | General Counsel | Jan 31, 2026 | Option Exercise | — | 15,500 | — | 49,972 | |
URGN | Smith Jason Drew | — | Sep 8, 2025 | Proposed Sale | $18.88 | 1,520 | $28.7K | — | |
URGN | Smith Jason Drew | — | Jul 28, 2025 | Proposed Sale | $18.95 | 7,522 | $142.5K | — |